Botry-Zen, the company that owns the rights to a biological control preventing botrytis in grapevines, will attain a listing on the New Zealand stock exchange in February, it said. The company has already had to return around NZ$115m in over-subscriptions for the NZ$5m share issue. Botry-Zen’s 166m shares were issued at 10c each but have been trading in the mid-20c range, until rising to their current level of 40c two weeks ago.
Subscribe to Just Drinks
Join over 80,000 beverage industry professionals by unlocking full access for just $1 (plus VAT if applicable)
Already a Member? LOGIN HERE
Just Drinks membership gives you:
- Unlimited access to Just Drinks content including in-depth analysis, exclusive blogs, industry executive interviews and management briefings
- Unbeatable market coverage from wine and beer, to soft drinks
- Unrivalled apparel industry comment from Olly Wehring, Andy Morton and leading industry analysts
Want multi-user access? Explore our multi-user & corporate memberships
70% of the beverage companies in the Forbes Global 2000 use Just Drinks
Share this article
